Mohamed H. Sayegh
Mohamed H. Sayegh
Executive Vice President, American University of Beirut
Verified email at
Cited by
Cited by
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
EM Zeisberg, O Tarnavski, M Zeisberg, AL Dorfman, JR McMullen, ...
Nature medicine 13 (8), 952-961, 2007
Identification of cells initiating human melanomas
T Schatton, GF Murphy, NY Frank, K Yamaura, AM Waaga-Gasser, ...
Nature 451 (7176), 345-349, 2008
Tissue expression of PD-L1 mediates peripheral T cell tolerance
ME Keir, SC Liang, I Guleria, YE Latchman, A Qipo, LA Albacker, ...
Journal of Experimental Medicine 203 (4), 883-895, 2006
Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens
HL Weiner, A Friedman, A Miller, SJ Khoury, A Al-Sabbagh, L Santos, ...
Annual review of immunology 12 (1), 809-837, 1994
Delayed graft function in kidney transplantation
N Perico, D Cattaneo, MH Sayegh, G Remuzzi
The Lancet 364 (9447), 1814-1827, 2004
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
MJI Ansari, AD Salama, T Chitnis, RN Smith, H Yagita, H Akiba, ...
The Journal of experimental medicine 198 (1), 63-69, 2003
The role of T-cell costimulatory activation pathways in transplant rejection
MH Sayegh, LA Turka
New England Journal of Medicine 338 (25), 1813-1821, 1998
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
AD Wells, XC Li, Y Li, MC Walsh, XX Zheng, Z Wu, G Nuņez, A Tang, ...
Nature medicine 5 (11), 1303-1307, 1999
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma
NY Frank, A Margaryan, Y Huang, T Schatton, AM Waaga-Gasser, ...
Cancer research 65 (10), 4320-4333, 2005
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
MH Sayegh, E Akalin, WW Hancock, ME Russell, CB Carpenter, ...
The Journal of experimental medicine 181 (5), 1869-1874, 1995
Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question
EJ Suchin, PB Langmuir, E Palmer, MH Sayegh, AD Wells, LA Turka
The Journal of Immunology 166 (2), 973-981, 2001
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
T Wekerle, J Kurtz, H Ito, JV Ronquillo, V Dong, G Zhao, J Shaffer, ...
Nature medicine 6 (4), 464-469, 2000
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis
AD Salama, T Chitnis, J Imitola, MJI Ansari, H Akiba, F Tushima, M Azuma, ...
The Journal of experimental medicine 198 (1), 71-78, 2003
Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes
R Abdi, P Fiorina, CN Adra, M Atkinson, MH Sayegh
Diabetes 57 (7), 1759-1767, 2008
Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes
WW Hancock, R Buelow, MH Sayegh, LA Turka
Nature medicine 4 (12), 1392-1396, 1998
Immunosuppressive strategies in transplantation
MD Denton, CC Magee, MH Sayegh
The Lancet 353 (9158), 1083-1091, 1999
Transplantation 50 years later: progress, challenges, and promises
MH Sayegh, CB Carpenter
The New England journal of medicine 351 (26), 2761-2766, 2004
Effects of explosive brain death on cytokine activation of peripheral organs in the Rat1
M Takada, KC Nadeau, WW Hancock, HS Mackenzie, GD Shaw, ...
Transplantation 65 (12), 1533-1542, 1998
Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
WW Hancock, MH Sayegh, XG Zheng, R Peach, PS Linsley, LA Turka
Proceedings of the National Academy of Sciences 93 (24), 13967-13972, 1996
Anaritide in acute tubular necrosis
RL Allgren, TC Marbury, SN Rahman, LS Weisberg, AZ Fenves, ...
New England Journal of Medicine 336 (12), 828-834, 1997
The system can't perform the operation now. Try again later.
Articles 1–20